Labcorp Holdings Inc. (LH)
Cinctive Capital Management LP Makes New Investment in Labcorp Holdings Inc. $LH
Cinctive Capital Management LP bought a new stake in shares of Labcorp Holdings Inc. (NYSE: LH) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 11,486 shares of the medical research company's stock, valued at approximately $3,297,000. Other hedge funds have also made
Labcorp Holdings Inc. $LH Stock Position Lifted by 8 Knots Management LLC
8 Knots Management LLC raised its stake in Labcorp Holdings Inc. (NYSE: LH) by 96.6% during the undefined quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 204,859 shares of the medical research company's stock after buying an additional 100,675 shares during the quarter. Labcorp
Glenmede Investment Management LP Sells 4,365 Shares of Labcorp Holdings Inc. $LH
Glenmede Investment Management LP cut its holdings in Labcorp Holdings Inc. (NYSE: LH) by 1.6% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 270,547 shares of the medical research company's stock after selling 4,365 shares during the quarter. Glenmede Investment Management
Labcorp Holdings (LH) is a Top-Ranked Value Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is This the Right Time to Hold Labcorp Stock in Your Portfolio?
LH eyes growth via specialty test expansion, acquisitions and LaunchPad savings, but currency headwinds and macro pressures cloud the outlook.
Why Labcorp Holdings (LH) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Labcorp Holdings (LH) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Labcorp Q4 Earnings Beat, Revenues Miss, Stock Down in Pre-Market
LH beats Q4 EPS estimates with 18% growth, but a revenue miss and cautious investor reaction push shares lower in pre-market trading.
Labcorp (LH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Labcorp (LH) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Labcorp Holdings (LH) Q4 Earnings Surpass Estimates
Labcorp Holdings (LH) came out with quarterly earnings of $4.07 per share, beating the Zacks Consensus Estimate of $3.95 per share. This compares to earnings of $3.45 per share a year ago.
Will Labcorp (LH) Beat Estimates Again in Its Next Earnings Report?
Labcorp (LH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Stay Ahead of the Game With Labcorp (LH) Q4 Earnings: Wall Street's Insights on Key Metrics
Besides Wall Street's top-and-bottom-line estimates for Labcorp (LH), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.
